Klaudia Steplewski
GlaxoSmithKline (United States)(US)BridgeBio (United States)(US)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Lung Cancer Treatments and Mutations, Neuropeptides and Animal Physiology, Peroxisome Proliferator-Activated Receptors, Receptor Mechanisms and Signaling
Most-Cited Works
- → The Orphan G Protein-coupled Receptors GPR41 and GPR43 Are Activated by Propionate and Other Short Chain Carboxylic Acids(2003)2,311 cited
- → AXOR12, a Novel Human G Protein-coupled Receptor, Activated by the Peptide KiSS-1(2001)897 cited
- → Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer(2009)661 cited
- → Molecular Identification of High and Low Affinity Receptors for Nicotinic Acid(2003)538 cited
- → A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas(2014)357 cited
- → Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1(1997)230 cited
- → Immunization against rabies with plant-derived antigen(1998)219 cited
- → Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases(2011)160 cited
- → Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators(2004)102 cited
- → Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in rats(2004)71 cited